CEO: Mr. William J. Enright MBA

IPO: 2021-04-30

Headquarters: US

Employees: 33

Homepage

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Cyteir Therapeutics Inc

Seagen Inc

IPI Legacy Liquidation Co

LianBio ADR

PHAXIAM Therapeutics SA